SEARCH
India may approve emergency use of Russian Sputnik V vaccine, expert panel to meet today
India Today
2021-04-12
Views
136
Description
Share / Embed
Download This Video
Report
A top panel of experts is meeting on Monday to take up the application for emergency use authorisation of Russian Covid-19 vaccine Sputnik V.
If the Russian vaccine gets the nod, it will be the third Covid-19 vaccine to be used in India after Covishield and Covaxin.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x80kb83" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:09
India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI
04:28
Vaccine Mixing Study Approved DGCI Approves Covaxin + Covishield Trials NewsX
01:05
India Approves 2 COVID-19 Vaccines: Covaxin, Covishield Vaccines 110% सुरक्षित
01:37
Covishield at Rs 780, Covaxin Rs 1410, Sputnik At Rs 1145: COVID Vaccine Prices Capped For Pvt Hosps
03:58
भारतातील ३ लसींपैकी कोणती लस चांगली? Which Vaccine Is Better In India? Covaxin | Covishield |Sputnik
01:37
Covishield at Rs 780, Covaxin Rs 1410, Sputnik At Rs 1145: COVID Vaccine Prices Capped For Pvt Hosps
28:42
Covaxin vs Covishield vs Sputnik வித்தியாசம் என்ன ? Best Corona vaccine எது?
04:24
Corona Vaccine कैसे काम करती है और क्या है Sputnik V, Covaxin, Covishield के Side Effects
03:05
India Approves Two COVID-19 Vaccines: Covishield ও Covaxin ব্যবহারে অনুমোদন, বিরোধীদের তোপ
05:09
Covishield vs Covaxin: A comparison of the two Covid-19 vaccines approved in India
01:40:04
India approves Covishield, Covaxin vaccines: Road to Covid-free India?
01:25
Covaxin Emergency Use:India approves Serum-Oxford, Bharat Biotech's COVID vaccines for Emergency Use
